Voting Rights Announcements | 19 January 2015 16:37
STRATEC Biomedical AG
19.01.2015 16:37
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
BNP Paribas Investment Partners S.A., Paris, France has notified us
pursuant to sec. 21 para. 1 WpHG on 15 January 2015, that on 15 January
2015 the share of voting rights in STRATEC Biomedical AG, Birkenfeld,
Germany, ISIN: DE0007289001 went above the threshold of 3% and that the
percentage of voting rights on that day amounted to 3.02% (356,478 voting
rights).
Of these voting rights 3.02% (356,478 voting rights) are attributable to
BNP Paribas Investment Partners S.A., pursuant to sec. 22 para. 1 sent. 1
no. 1 WpHG.
Also, of these voting rights 2.95% (347,651 voting rights) are attributable
to BNP Paribas Investment Partners S.A., pursuant to sec. 22 para. 1 sent.
1 no. 6 in connection with sent. 2 WpHG.
19.01.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: STRATEC Biomedical AG
Gewerbestr. 37
75217 Birkenfeld
Germany
Internet: www.stratec.com
End of Announcement DGAP News-Service
---------------------------------------------------------------------------